-
1
-
-
84907560394
-
-
WHO fact sheet N0 164. Hepatitis C World Health Organization: Geneva, updated July; (accessed June 11, 2014)
-
WHO fact sheet N0 164. Hepatitis C; World Health Organization: Geneva, updated July 2013; http://www.who.int/mediacentre/factsheets/fs164/en/ (accessed June 11, 2014).
-
(2013)
-
-
-
2
-
-
80055007298
-
-
Centers for Disease Control: Atlanta; (accessed June 11, 2014)
-
Hepatitis C. Information for Health Professionals; Centers for Disease Control: Atlanta; http://www.cdc.gov/hepatitis/hcv/# (accessed June 11, 2014).
-
Hepatitis C. Information for Health Professionals
-
-
-
3
-
-
84872403501
-
HCV in liver transplantation
-
Germani, G.; Tsochatzis, E.; Papastergiou, V.; Burroughs, A. K. HCV in liver transplantation Semin. Immunopathol. 2013, 35 (1) 101-110
-
(2013)
Semin. Immunopathol.
, vol.35
, Issue.1
, pp. 101-110
-
-
Germani, G.1
Tsochatzis, E.2
Papastergiou, V.3
Burroughs, A.K.4
-
4
-
-
84355161578
-
Immunosuppression, Liver Injury and Post-transplant HCV Recurrence
-
Ciesek, S.; Wedemeyer, H. Immunosuppression, Liver Injury and Post-transplant HCV Recurrence J. Viral Hepatitis 2012, 19 (1) 1-8
-
(2012)
J. Viral Hepatitis
, vol.19
, Issue.1
, pp. 1-8
-
-
Ciesek, S.1
Wedemeyer, H.2
-
5
-
-
84896055529
-
Approaches to hepatitis C treatment and cure using NS5A inhibitors
-
Kohler, J. J.; Nettles, J. H.; Amblard, F.; Hurwitz, S. J.; Bassi, L.; Stanton, R. A.; Ehteshami, M.; Schinazi, R. F. Approaches to hepatitis C treatment and cure using NS5A inhibitors Infect. Drug Resist. 2014, 7, 41-56
-
(2014)
Infect. Drug Resist.
, vol.7
, pp. 41-56
-
-
Kohler, J.J.1
Nettles, J.H.2
Amblard, F.3
Hurwitz, S.J.4
Bassi, L.5
Stanton, R.A.6
Ehteshami, M.7
Schinazi, R.F.8
-
6
-
-
82455188181
-
Multiple Ascending Dose Study of BMS-790052, a Nonstructural Protein 5A Replication Complex Inhibitor, in Patients Infected with Hepatitis C Virus Genotype 1
-
Nettles, R. E.; Gao, M.; Bifano, M.; Chung, E.; Persson, A.; Marbury, T. C.; Goldwater, R.; DeMicco, M. P.; Rodriguez-Torres, M.; Vutikullird, A.; Fuentes, E.; Lawitz, E.; Lopez-Talavera, J. C.; Grasela, D. M. Multiple Ascending Dose Study of BMS-790052, a Nonstructural Protein 5A Replication Complex Inhibitor, in Patients Infected with Hepatitis C Virus Genotype 1 Hepatology 2011, 54, 1956-1965
-
(2011)
Hepatology
, vol.54
, pp. 1956-1965
-
-
Nettles, R.E.1
Gao, M.2
Bifano, M.3
Chung, E.4
Persson, A.5
Marbury, T.C.6
Goldwater, R.7
Demicco, M.P.8
Rodriguez-Torres, M.9
Vutikullird, A.10
Fuentes, E.11
Lawitz, E.12
Lopez-Talavera, J.C.13
Grasela, D.M.14
-
7
-
-
81155138596
-
-
Patent application WO-2008/021927
-
Bachand, C.; Belema, M.; Deon, D. H.; Good, A. C.; Goodrich, J.; James, C. A.; Lavoie, R.; Lopez, O. D.; Martel, A.; Meanwell, N. A.; Nguyen, V. N.; Romine, J. L.; Ruediger, E. H.; Snyder, L. B.; St. Laurent, D. R.; Yang, F.; Langley, D. R.; Wang, G.; Hamann, L. G. Hepatitis C virus inhibitors. Patent application WO-2008/021927, 2008.
-
(2008)
Hepatitis C Virus Inhibitors
-
-
Bachand, C.1
Belema, M.2
Deon, D.H.3
Good, A.C.4
Goodrich, J.5
James, C.A.6
Lavoie, R.7
Lopez, O.D.8
Martel, A.9
Meanwell, N.A.10
Nguyen, V.N.11
Romine, J.L.12
Ruediger, E.H.13
Snyder, L.B.14
St. Laurent, D.R.15
Yang, F.16
Langley, D.R.17
Wang, G.18
Hamann, L.G.19
-
8
-
-
81155138596
-
-
Patent application WO-2008/021928
-
Bachand, C.; Belema, M.; Deon, D. H.; Good, A. C.; Goodrich, J.; James, C. A.; Lavoie, R.; Lopez, O. D.; Martel, A.; Meanwell, N. A.; Nguyen, V. N.; Romine, J. L.; Ruediger, E. H.; Snyder, L. B.; St. Laurent, D. R.; Yang, F.; Langley, D. R.; Wang, G.; Hamann, L. G. Hepatitis C virus inhibitors. Patent application WO-2008/021928, 2008.
-
(2008)
Hepatitis C Virus Inhibitors
-
-
Bachand, C.1
Belema, M.2
Deon, D.H.3
Good, A.C.4
Goodrich, J.5
James, C.A.6
Lavoie, R.7
Lopez, O.D.8
Martel, A.9
Meanwell, N.A.10
Nguyen, V.N.11
Romine, J.L.12
Ruediger, E.H.13
Snyder, L.B.14
St. Laurent, D.R.15
Yang, F.16
Langley, D.R.17
Wang, G.18
Hamann, L.G.19
-
9
-
-
81155138596
-
-
Patent application WO-2008/021936
-
Bachand, C.; Belema, M.; Deon, D. H.; Good, A. C.; Goodrich, J.; James, C. A.; Lavoie, R.; Lopez, O. D.; Martel, A.; Meanwell, N. A.; Nguyen, V. N.; Romine, J. L.; Ruediger, E. H.; Snyder, L. B.; St. Laurent, D. R.; Yang, F.; Langley, D. R.; Wang, G.; Hamann, L. G. Hepatitis C virus inhibitors. Patent application WO-2008/021936, 2008.
-
(2008)
Hepatitis C Virus Inhibitors
-
-
Bachand, C.1
Belema, M.2
Deon, D.H.3
Good, A.C.4
Goodrich, J.5
James, C.A.6
Lavoie, R.7
Lopez, O.D.8
Martel, A.9
Meanwell, N.A.10
Nguyen, V.N.11
Romine, J.L.12
Ruediger, E.H.13
Snyder, L.B.14
St. Laurent, D.R.15
Yang, F.16
Langley, D.R.17
Wang, G.18
Hamann, L.G.19
-
13
-
-
84896290194
-
-
Patent application WO-2010/132601
-
Guo, H.; Kato, D.; Kirschberg, T. A.; Liu, H.; Link, J. O.; Mitchell, M. L.; Parrish, J. P.; Squres, N.; Sun, J.; Taylor, J.; Bacon, E. M.; Kanales, E.; Cho, A.; Cottel, J. J.; Desai, M. C.; Halcomb, R. L.; Krugowski, E. S.; Lazerwith, S. E.; Liu, Q.; Mackman, R.; Pyun, H.-J.; Saugier, J. H.; Trenkle, J. D.; Tsu, W. C.; Vivian, R. W.; Schroeder, S. D.; Watkins, W. J.; Xu, L.; Yang, Z.-Y.; Kellar, T.; Sheng, X.; Clarke, M. O.N. H.; Chou, C.-H.; Graupe, M.; Jin, H.; Mcfadden, R.; Mish, M. R.; Metobo, S. E.; Phillips, B. W.; Venkataramani, C. Antiviral compounds. Patent application WO-2010/132601, 2010.
-
(2010)
Antiviral Compounds
-
-
Guo, H.1
Kato, D.2
Kirschberg, T.A.3
Liu, H.4
Link, J.O.5
Mitchell, M.L.6
Parrish, J.P.7
Squres, N.8
Sun, J.9
Taylor, J.10
Bacon, E.M.11
Kanales, E.12
Cho, A.13
Cottel, J.J.14
Desai, M.C.15
Halcomb, R.L.16
Krugowski, E.S.17
Lazerwith, S.E.18
Liu, Q.19
Mackman, R.20
Pyun, H.-J.21
Saugier, J.H.22
Trenkle, J.D.23
Tsu, W.C.24
Vivian, R.W.25
Schroeder, S.D.26
Watkins, W.J.27
Xu, L.28
Yang, Z.-Y.29
Kellar, T.30
Sheng, X.31
Clarke, M.O.N.H.32
Chou, C.-H.33
Graupe, M.34
Jin, H.35
McFadden, R.36
Mish, M.R.37
Metobo, S.E.38
Phillips, B.W.39
Venkataramani, C.40
more..
-
14
-
-
84896308812
-
Discovery and Development of Hepatitis C Virus NS5A Replication Complex Inhibitors
-
Belema, M.; Lopez, O. D.; Bender, J. A.; Romine, J. L.; St. Laurent, D. R.; Langley, D. R.; Lemm, J. A.; OBoyle, D. R., II; Sun, J.-H.; Wang, C.; Fridell, R. A.; Meanwell, N. A. Discovery and Development of Hepatitis C Virus NS5A Replication Complex Inhibitors J. Med. Chem. 2014, 57 (5) 1643-1672
-
(2014)
J. Med. Chem.
, vol.57
, Issue.5
, pp. 1643-1672
-
-
Belema, M.1
Lopez, O.D.2
Bender, J.A.3
Romine, J.L.4
St. Laurent, D.R.5
Langley, D.R.6
Lemm, J.A.7
Oboyle, D.R.I.I.8
Sun, J.-H.9
Wang, C.10
Fridell, R.A.11
Meanwell, N.A.12
-
15
-
-
84907560393
-
A Study of the PK, Safety and Antiviral Activity of A-831 in HCV Carriers (CP104) [NCT00522808]
-
U.S. National Library of Medicine: Bethesda, MD, September 26, (Accessed June 11, 2014)
-
A Study of the PK, Safety and Antiviral Activity of A-831 in HCV Carriers (CP104) [NCT00522808]. ClinicalTrials.gov; U.S. National Library of Medicine: Bethesda, MD, September 26, 2008; http://clinicaltrials.gov/ct2/show/NCT00522808 (Accessed June 11, 2014).
-
(2008)
ClinicalTrials.gov
-
-
-
16
-
-
84896295869
-
The discovery of ledipasvir (GS-5885), a potent once-daily oral NS5A inhibitor for the treatment of hepatitis C virus infection
-
Link, J. O.; Taylor, J. G.; Xu, L.; Mitchell, M.; Guo, H.; Liu, H.; Kato, D.; Kirschberg, T.; Sun, J.; Squires, N.; Parrish, J.; Keller, T.; Yang, Z.-Y.; Yang, C.; Matles, M.; Wang, Y.; Wang, K.; Cheng, G.; Tian, Y.; Mogalian, E.; Mondou, E.; Cornpropst, M.; Perry, J.; Desai, M. C. The discovery of ledipasvir (GS-5885), a potent once-daily oral NS5A inhibitor for the treatment of hepatitis C virus infection J. Med. Chem. 2014, 57 (5) 2033-2046
-
(2014)
J. Med. Chem.
, vol.57
, Issue.5
, pp. 2033-2046
-
-
Link, J.O.1
Taylor, J.G.2
Xu, L.3
Mitchell, M.4
Guo, H.5
Liu, H.6
Kato, D.7
Kirschberg, T.8
Sun, J.9
Squires, N.10
Parrish, J.11
Keller, T.12
Yang, Z.-Y.13
Yang, C.14
Matles, M.15
Wang, Y.16
Wang, K.17
Cheng, G.18
Tian, Y.19
Mogalian, E.20
Mondou, E.21
Cornpropst, M.22
Perry, J.23
Desai, M.C.24
more..
-
17
-
-
84870441080
-
Small molecule inhibitors of the hepatitis C virus-encoded NS5A protein
-
Belda, O.; Targett-Adams, P. Small molecule inhibitors of the hepatitis C virus-encoded NS5A protein Virus Res. 2012, 170, 1-14
-
(2012)
Virus Res.
, vol.170
, pp. 1-14
-
-
Belda, O.1
Targett-Adams, P.2
-
18
-
-
84891533036
-
Preclinical characterization of GSK2336805, a novel inhibitor of hepatitis C virus replication that selects for resistance in NS5A
-
Walker, J.; Crosby, R.; Wang, A.; Woldu, E.; Vamathevan, J.; Voitenleitner, C.; You, S.; Remlinger, K.; Duan, M.; Kazmierski, W.; Hamatake, R. Preclinical characterization of GSK2336805, a novel inhibitor of hepatitis C virus replication that selects for resistance in NS5A Antimicrob. Agents Chemother. 2014, 58, 38-47
-
(2014)
Antimicrob. Agents Chemother.
, vol.58
, pp. 38-47
-
-
Walker, J.1
Crosby, R.2
Wang, A.3
Woldu, E.4
Vamathevan, J.5
Voitenleitner, C.6
You, S.7
Remlinger, K.8
Duan, M.9
Kazmierski, W.10
Hamatake, R.11
-
19
-
-
82955200701
-
Idenix NS5A HCV replication inhibitors with low picomolar, pangenotypic in vitro antiviral activity
-
Abstract 815 - S327
-
Dousson, C. B.; La Colla, M.; Chapron, C.; Bilello, J. P.; McCarville, J. F.; Seifer, M.; Parsy, C.; Dukhan, D.; Pierra, C.; Surleraux, D.; Standring, D. N. Idenix NS5A HCV replication inhibitors with low picomolar, pangenotypic in vitro antiviral activity J. Hepatol. 2011, 54, S326-S327 Abstract 815
-
(2011)
J. Hepatol.
, vol.54
, pp. 326
-
-
Dousson, C.B.1
La Colla, M.2
Chapron, C.3
Bilello, J.P.4
McCarville, J.F.5
Seifer, M.6
Parsy, C.7
Dukhan, D.8
Pierra, C.9
Surleraux, D.10
Standring, D.N.11
-
20
-
-
84896297290
-
Hepatitis C virus NS5A replication complex inhibitors. Part 6: Discovery of a novel and highly potent biarylimidazole chemotype with inhibitory activity toward genotypes 1a and 1b replicons
-
Belema, M.; Nguyen, V. N.; Romine, J. L.; St. Laurent, D. R.; Lopez, O. D.; Goodrich, J. T.; Nower, P. T.; OBoyle, D. R., 2nd; Lemmm, J. A.; Fridell, R. A.; Gao, M.; Fang, H.; Krause, R. G.; Wang, Y. K.; Oliver, A. J.; Good, A. C.; Knipe, J. O.; Meanwell, N. A.; Snyder, L. B. Hepatitis C virus NS5A replication complex inhibitors. Part 6: Discovery of a novel and highly potent biarylimidazole chemotype with inhibitory activity toward genotypes 1a and 1b replicons J. Med. Chem. 2014, 57 (5) 1995-2012
-
(2014)
J. Med. Chem.
, vol.57
, Issue.5
, pp. 1995-2012
-
-
Belema, M.1
Nguyen, V.N.2
Romine, J.L.3
St. Laurent, D.R.4
Lopez, O.D.5
-
21
-
-
84889888952
-
Discovery of MK-8742: An HCV NS5A inhibitor with broad genotype activity
-
Coburn, C. A.; Meinke, P. T.; Chang, W.; Fandozzi, C. M.; Graham, D. J.; Hu, B.; Huang, Q.; Kargman, S.; Kozlowski, J.; Liu, R.; McCauley, J. A.; Nomeir, A. A.; Soll, R. M.; Vacca, J. P.; Wang, D.; Wu, H.; Zhong, B.; Olsen, D. B.; Ludmerer, S. W. Discovery of MK-8742: an HCV NS5A inhibitor with broad genotype activity ChemMedChem 2013, 8, 1930-1940
-
(2013)
ChemMedChem
, vol.8
, pp. 1930-1940
-
-
Coburn, C.A.1
Meinke, P.T.2
Chang, W.3
Fandozzi, C.M.4
Graham, D.J.5
Hu, B.6
Huang, Q.7
Kargman, S.8
Kozlowski, J.9
Liu, R.10
McCauley, J.A.11
Nomeir, A.A.12
Soll, R.M.13
Vacca, J.P.14
Wang, D.15
Wu, H.16
Zhong, B.17
Olsen, D.B.18
Ludmerer, S.W.19
-
22
-
-
84896268219
-
Discovery of ABT-267, a pangenotypic inhibitor of HCV NS5A
-
DeGoey, D. A.; Randolph, J. T.; Liu, D.; Pratt, J.; Hutchins, C.; Donner, P.; Krueger, A. C.; Matulenko, M.; Patel, S.; Motter, C. E.; Nelson, L.; Keddy, R.; Tufano, M.; Caspi, D. D.; Krishnan, P.; Mistry, N.; Koev, G.; Reisch, T. J.; Mondal, R.; Pilot-Matias, T.; Gao, Y.; Beno, D. W. A.; Maring, C. J.; Molla, A.; Dumas, E.; Campbell, A.; Williams, L.; Collins, C.; Wagner, R.; Kati, W. M. Discovery of ABT-267, a pangenotypic inhibitor of HCV NS5A J. Med. Chem. 2014, 57 (5) 2047-2057
-
(2014)
J. Med. Chem.
, vol.57
, Issue.5
, pp. 2047-2057
-
-
Degoey, D.A.1
Randolph, J.T.2
Liu, D.3
Pratt, J.4
Hutchins, C.5
Donner, P.6
Krueger, A.C.7
Matulenko, M.8
Patel, S.9
Motter, C.E.10
Nelson, L.11
Keddy, R.12
Tufano, M.13
Caspi, D.D.14
Krishnan, P.15
Mistry, N.16
Koev, G.17
Reisch, T.J.18
Mondal, R.19
Pilot-Matias, T.20
Gao, Y.21
Beno, D.W.A.22
Maring, C.J.23
Molla, A.24
Dumas, E.25
Campbell, A.26
Williams, L.27
Collins, C.28
Wagner, R.29
Kati, W.M.30
more..
-
24
-
-
84872046997
-
Palladium-free synthesis of unsymmetrical diarylethynes by cross-coupling reaction of alkynylboronates with aryl iodides catalyzed by CuCl
-
Ogawa, D.; Li, J.; Suetsugu, M.; Jiao, J.; Iwasaki, M.; Nishihara, Y. Palladium-free synthesis of unsymmetrical diarylethynes by cross-coupling reaction of alkynylboronates with aryl iodides catalyzed by CuCl Tetrahedron Lett. 2013, 54 (6) 518-521
-
(2013)
Tetrahedron Lett.
, vol.54
, Issue.6
, pp. 518-521
-
-
Ogawa, D.1
Li, J.2
Suetsugu, M.3
Jiao, J.4
Iwasaki, M.5
Nishihara, Y.6
-
25
-
-
84907522752
-
-
Patent US 20070129364
-
Dong, H.; Foreman, K.; Li, A.; Mulvihill, M. J.; Panicker, B.; Steinig, A. G.; Stolz, K. M.; Weng, Q.; Jin, M.; Volk, B.; Wang, J.; Wang, T.; Beard, J. D. Preparation of pyrrolo[2,3- b ]pyridines as inhibitors of kinases for the treatment of cancer. Patent US 20070129364, 2007.
-
(2007)
Preparation of pyrrolo[2,3- B ]Pyridines As Inhibitors of Kinases for the Treatment of Cancer
-
-
Dong, H.1
Foreman, K.2
Li, A.3
Mulvihill, M.J.4
Panicker, B.5
Steinig, A.G.6
Stolz, K.M.7
Weng, Q.8
Jin, M.9
Volk, B.10
Wang, J.11
Wang, T.12
Beard, J.D.13
-
26
-
-
84907560392
-
-
(accessed June 11, 2014)
-
Allachem HCV Platform; http://allachem.com/pipeline/hcv-platform; (accessed June 11, 2014).
-
Allachem HCV Platform
-
-
-
27
-
-
66149115122
-
Crystal structure of a novel dimeric form of NS5A domain i protein from hepatitis C virus
-
Love, R. A.; Brodsky, O.; Hickey, M. J.; Wells, P. A.; Cronin, C. N. Crystal structure of a novel dimeric form of NS5A domain I protein from hepatitis C virus J. Virol. 2009, 83 (9) 4395-4403
-
(2009)
J. Virol.
, vol.83
, Issue.9
, pp. 4395-4403
-
-
Love, R.A.1
Brodsky, O.2
Hickey, M.J.3
Wells, P.A.4
Cronin, C.N.5
-
28
-
-
19644393931
-
Structure of the zinc-binding domain of an essential component of the hepatitis C virus replicase
-
Tellinghuisen, T. L.; Marcotrigiano, J.; Rice, C. M. Structure of the zinc-binding domain of an essential component of the hepatitis C virus replicase Nature 2005, 435 (7040) 374-379
-
(2005)
Nature
, vol.435
, Issue.7040
, pp. 374-379
-
-
Tellinghuisen, T.L.1
Marcotrigiano, J.2
Rice, C.M.3
-
29
-
-
84872836019
-
Resistance studies of a dithiazol analogue, DBPR110, as a potential hepatitis C virus inhibitor in replicon systems
-
Lin, H. M.; Wang, J. C.; Hu, H. S.; Wu, P. S.; Wang, W. H.; Wu, S. Y.; Yang, C. C.; Yeh, T. K.; Hsu, T. A.; Jiaang, W. T.; Chao, Y. S.; Chern, J. H.; Yueh, A. Resistance studies of a dithiazol analogue, DBPR110, as a potential hepatitis C virus inhibitor in replicon systems Antimicrob. Agents Chemother. 2013, 57, 723-733
-
(2013)
Antimicrob. Agents Chemother.
, vol.57
, pp. 723-733
-
-
Lin, H.M.1
Wang, J.C.2
Hu, H.S.3
Wu, P.S.4
Wang, W.H.5
Wu, S.Y.6
Yang, C.C.7
Yeh, T.K.8
Hsu, T.A.9
Jiaang, W.T.10
Chao, Y.S.11
Chern, J.H.12
Yueh, A.13
-
30
-
-
77952035218
-
Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect
-
Gao, M.; Nettles, R. E.; Belema, M.; Snyder, L. B.; Nguyen, V. N.; Fridell, R. A.; Serrano-Wu, M. H.; Langley, D. R.; Sun, J.-H.; OBoyle, D. R., II; Lemm, J. A.; Wang, C.; Knipe, J. O.; Chien, C.; Colonno, R. J.; Grasela, D. M.; Meanwell, N. A.; Hamann, L. G. Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect Nature 2010, 465, 96-100
-
(2010)
Nature
, vol.465
, pp. 96-100
-
-
Gao, M.1
Nettles, R.E.2
Belema, M.3
Snyder, L.B.4
Nguyen, V.N.5
Fridell, R.A.6
Serrano-Wu, M.H.7
Langley, D.R.8
Sun, J.-H.9
Oboyle, D.R.I.I.10
Lemm, J.A.11
Wang, C.12
Knipe, J.O.13
Chien, C.14
Colonno, R.J.15
Grasela, D.M.16
Meanwell, N.A.17
Hamann, L.G.18
-
31
-
-
77956116880
-
Resistance analysis of the hepatitis C virus NS5A inhibitor BMS-790052 in an in vitro replicon system
-
Fridell, R. A.; Qiu, D.; Wang, C.; Valera, L.; Gao, M. Resistance analysis of the hepatitis C virus NS5A inhibitor BMS-790052 in an in vitro replicon system Antimicrob. Agents Chemother. 2010, 54, 3641-3650
-
(2010)
Antimicrob. Agents Chemother.
, vol.54
, pp. 3641-3650
-
-
Fridell, R.A.1
Qiu, D.2
Wang, C.3
Valera, L.4
Gao, M.5
-
32
-
-
84896306338
-
-
Patent application WO-2010/144646
-
DeGoey, D. A.; Kati, W. M.; Hutchins, C. W.; Donner, P. L.; Krueger, A. C.; Randolph, J. T.; Motter, C. E.; Nelson, L. T.; Patel, S. V.; Matulenko, M. A.; Keddy, R. G.; Jinkerson, T. K.; Soltwedel, T. N.; Hutchinson, D. K.; Flentge, C. A.; Wagner, R.; Maring, C. J.; Tufano, M. D.; Betebenner, D. A.; Rockway, T. W.; Liu, D.; Pratt, J. K.; Lavin, M. J.; Sarris, K.; Woller, K. R.; Wagaw, S. H.; Califano, J. C.; Li, W. Anti-viral compounds. Patent application WO-2010/144646, 2010.
-
(2010)
Anti-viral Compounds
-
-
Degoey, D.A.1
Kati, W.M.2
Hutchins, C.W.3
Donner, P.L.4
Krueger, A.C.5
Randolph, J.T.6
Motter, C.E.7
Nelson, L.T.8
Patel, S.V.9
Matulenko, M.A.10
Keddy, R.G.11
Jinkerson, T.K.12
Soltwedel, T.N.13
Hutchinson, D.K.14
Flentge, C.A.15
Wagner, R.16
Maring, C.J.17
Tufano, M.D.18
Betebenner, D.A.19
Rockway, T.W.20
Liu, D.21
Pratt, J.K.22
Lavin, M.J.23
Sarris, K.24
Woller, K.R.25
Wagaw, S.H.26
Califano, J.C.27
Li, W.28
more..
-
33
-
-
84863148442
-
Hepatitis C virus RNA elimination and development of resistance in replicon cells treated with BMS-790052
-
Wang, C.; Huang, H.; Valera, L.; Sun, J.-H.; OBoyle, D. R.; Nower, P. T.; Jia, L.; Qiu, D.; Huang, X.; Altaf, A.; Gao, M.; Fridell, R. A. Hepatitis C virus RNA elimination and development of resistance in replicon cells treated with BMS-790052 Antimicrob. Agents Chemother. 2012, 56, 1350-1358
-
(2012)
Antimicrob. Agents Chemother.
, vol.56
, pp. 1350-1358
-
-
Wang, C.1
Huang, H.2
Valera, L.3
Sun, J.-H.4
Oboyle, D.R.5
Nower, P.T.6
Jia, L.7
Qiu, D.8
Huang, X.9
Altaf, A.10
Gao, M.11
Fridell, R.A.12
-
34
-
-
84952980130
-
Targeting the NS5A protein of HCV: An emerging option
-
Cordek, D. G.; Bechtel, J. T.; Maynard, A. T.; Kazmierski, W. M.; Cameron, C. E. Targeting the NS5A protein of HCV: an emerging option Drugs Future 2011, 36, 691-711
-
(2011)
Drugs Future
, vol.36
, pp. 691-711
-
-
Cordek, D.G.1
Bechtel, J.T.2
Maynard, A.T.3
Kazmierski, W.M.4
Cameron, C.E.5
-
35
-
-
84898793116
-
A randomized, double-blind, multiple-dose study of the pan-genotypic NS5A inhibitor samatasvir in patients infected with hepatitis C virus genotype 1, 2, 3 or 4
-
Vince, B.; Hill, J. M.; Lawitz, E. J.; ORiordan, W.; Webster, L. R.; Gruener, D. M.; Mofsen, R. S.; Murillo, A.; Donovan, E.; Chen, J.; McCarville, J. F.; Sullivan-Bolyai, J. Z.; Mayers, D.; Zhou, X. J. A randomized, double-blind, multiple-dose study of the pan-genotypic NS5A inhibitor samatasvir in patients infected with hepatitis C virus genotype 1, 2, 3 or 4 J. Hepatol. 2014, 60 (5) 920-927
-
(2014)
J. Hepatol.
, vol.60
, Issue.5
, pp. 920-927
-
-
Vince, B.1
Hill, J.M.2
Lawitz, E.J.3
Oriordan, W.4
Webster, L.R.5
Gruener, D.M.6
Mofsen, R.S.7
Murillo, A.8
Donovan, E.9
Chen, J.10
McCarville, J.F.11
Sullivan-Bolyai, J.Z.12
Mayers, D.13
Zhou, X.J.14
-
36
-
-
84896304290
-
-
Patent application WO-2012/040923
-
Kozlowski, J. A.; Rosenblum, S. B.; Coburn, C. A.; Shankar, B. B.; Anilkumar, G.; Chen, L.; Dwyer, M. P.; Jiang, Y.; Keertikar, K. M.; Lavey, B. J.; Selyutin, O. B.; Tong, L.; Wong, M.; Yang, D.-Y.; Yu, W.; Zhou, G.; Wu, H.; Hu, B.; Zhong, B.; Sun, F.; Ji, T.; Shen, C. Preparation of tetracyclic indole derivatives for treatment of HCV infection. Patent application WO-2012/040923, 2012.
-
(2012)
Preparation of Tetracyclic Indole Derivatives for Treatment of HCV Infection
-
-
Kozlowski, J.A.1
Rosenblum, S.B.2
Coburn, C.A.3
Shankar, B.B.4
Anilkumar, G.5
Chen, L.6
Dwyer, M.P.7
Jiang, Y.8
Keertikar, K.M.9
Lavey, B.J.10
Selyutin, O.B.11
Tong, L.12
Wong, M.13
Yang, D.-Y.14
Yu, W.15
Zhou, G.16
Wu, H.17
Hu, B.18
Zhong, B.19
Sun, F.20
Ji, T.21
Shen, C.22
more..
-
37
-
-
84896279827
-
-
Patent application WO-2012/041014
-
Kozlowski, J. A.; Rosenblum, S. B.; Coburn, C. A.; Shankar, B. B.; Anilkumar, G. N.; Chen, L.; Dwyer, M. P.; Jiang, Y.; Keertikar, K. M.; Lavey, B. J.; Selyutin, O. B.; Tong, L.; Wong, M.; Yang, D.-Y.; Yu, W.; Zhou, G.; Wu, H.; Hu, B.; Zhong, B.; Sun, F.; Ji, T.; Shen, C.; Rizvi, R.; Zeng, Q. Preparation of tetracyclicindole derivatives and analogs for use in treatment of hepatitis C virus infection. Patent application WO-2012/041014, 2012.
-
(2012)
Preparation of Tetracyclicindole Derivatives and Analogs for Use in Treatment of Hepatitis C Virus Infection
-
-
Kozlowski, J.A.1
Rosenblum, S.B.2
Coburn, C.A.3
Shankar, B.B.4
Anilkumar, G.N.5
Chen, L.6
Dwyer, M.P.7
Jiang, Y.8
Keertikar, K.M.9
Lavey, B.J.10
Selyutin, O.B.11
Tong, L.12
Wong, M.13
Yang, D.-Y.14
Yu, W.15
Zhou, G.16
Wu, H.17
Hu, B.18
Zhong, B.19
Sun, F.20
Ji, T.21
Shen, C.22
Rizvi, R.23
Zeng, Q.24
more..
-
38
-
-
84901598261
-
The crystal structure of NS5A domain 1 from genotype 1a reveals new clues to the mechanism of action for dimeric HCV inhibitors
-
Lambert, S. M.; Langley, D. R.; Garnett, J. A.; Angell, R.; Hedgethorne, K.; Meanwell, N. A.; Matthews, S. J. The crystal structure of NS5A domain 1 from genotype 1a reveals new clues to the mechanism of action for dimeric HCV inhibitors Protein Sci. 2014, 23 (6) 723-734
-
(2014)
Protein Sci.
, vol.23
, Issue.6
, pp. 723-734
-
-
Lambert, S.M.1
Langley, D.R.2
Garnett, J.A.3
Angell, R.4
Hedgethorne, K.5
Meanwell, N.A.6
Matthews, S.J.7
-
39
-
-
84882870729
-
Characterizations of HCV NS5A replication complex inhibitors
-
OBoyle, D. R., 2nd; Sun, J.-H.; Nower, P. T.; Lemm, J. A.; Fridell, R. A.; Wang, C.; Romine, J. L.; Belema, M.; Nguyen, V. N.; Laurent, D. R. S.; Serrano-Wu, M.; Snyder, L. B.; Meanwell, N. A.; Langley, D. R.; Gao, M. Characterizations of HCV NS5A replication complex inhibitors Virology 2013, 444, 343-354
-
(2013)
Virology
, vol.444
, pp. 343-354
-
-
O'Boyle, D.R.1
Sun, J.-H.2
Nower, P.T.3
Lemm, J.A.4
Fridell, R.A.5
Wang, C.6
Romine, J.L.7
Belema, M.8
Nguyen, V.N.9
Laurent, D.R.S.10
Serrano-Wu, M.11
Snyder, L.B.12
Meanwell, N.A.13
Langley, D.R.14
Gao, M.15
-
40
-
-
84907521544
-
-
Molsoft LLC; (accessed June 11, 2014)
-
ICM Pro; Molsoft LLC; http://www.molsoft.com; (accessed June 11, 2014).
-
ICM Pro
-
-
-
41
-
-
0034888396
-
Effect of alpha interferon on the hepatitis C virus replicon
-
Guo, J. T.; Bichko, V. V.; Seeger, C. Effect of alpha interferon on the hepatitis C virus replicon J. Virol. 2001, 75, 8516-8523
-
(2001)
J. Virol.
, vol.75
, pp. 8516-8523
-
-
Guo, J.T.1
Bichko, V.V.2
Seeger, C.3
-
42
-
-
84892171046
-
-
(accessed June 11, 2014)
-
Thomson Reuters Integrity Database; http://integrity.thomson-pharma.com. (accessed June 11, 2014).
-
Thomson Reuters Integrity Database
-
-
-
43
-
-
84907560391
-
-
Presented at 243rd ACS National Meeting, San Diego, March 25-29, 2012
-
DeGoey, D. A.; Betebenner, D. A.; Grampovnik, D. J.; Iwasaki, N.; Liu, D.; Pratt, J. K.; Tufano, M. D.; He, W.; Krishnan, P.; Pilot-Matias, T. J.; Marsh, K. C.; Molla, A.; Kempf, D. J.; Maring, C. J. Discovery of novel inhibitors of HCV NS5A and proof of concept study in an HCV-infected chimpanzee. Presented at 243rd ACS National Meeting, San Diego, March 25-29, 2012, Abstract MEDI 169.
-
Discovery of Novel Inhibitors of HCV NS5A and Proof of Concept Study in An HCV-infected Chimpanzee
, pp. 169
-
-
Degoey, D.A.1
Betebenner, D.A.2
Grampovnik, D.J.3
Iwasaki, N.4
Liu, D.5
Pratt, J.K.6
Tufano, M.D.7
He, W.8
Krishnan, P.9
Pilot-Matias, T.J.10
Marsh, K.C.11
Molla, A.12
Kempf, D.J.13
Maring, C.J.14
-
44
-
-
84896272204
-
Hepatitis C virus NS5A replication complex inhibitors: The discovery of daclatasvir
-
Belema, M.; Nguyen, V. N.; Bachand, C.; Deon, D. H.; Goodrich, J. T.; James, C. A.; Lavoie, R.; Lopez, O. D.; Martel, A.; Romine, J. L.; Ruediger, E. H.; Snyder, L. B.; St. Laurent, D. R.; Yang, F.; Zhu, J.; Wong, H. S.; Langley, D. R.; Adams, S. P.; Cantor, G. H.; Chimalakonda, A.; Fura, A.; Johnson, B. M.; Knipe, J. O.; Parker, D. D.; Santone, K. S.; Fridell, R. A.; Lemm, J. A.; OBoyle, D. R., II; Colonno, R. J.; Gao, M.; Meanwell, N. A.; Hamann, L. G. Hepatitis C virus NS5A replication complex inhibitors: the discovery of daclatasvir J. Med. Chem. 2014, 57 (5) 2013-2032
-
(2014)
J. Med. Chem.
, vol.57
, Issue.5
, pp. 2013-2032
-
-
Belema, M.1
Nguyen, V.N.2
Bachand, C.3
Deon, D.H.4
Goodrich, J.T.5
James, C.A.6
Lavoie, R.7
Lopez, O.D.8
Martel, A.9
Romine, J.L.10
Ruediger, E.H.11
Snyder, L.B.12
St. Laurent, D.R.13
Yang, F.14
Zhu, J.15
Wong, H.S.16
Langley, D.R.17
Adams, S.P.18
Cantor, G.H.19
Chimalakonda, A.20
Fura, A.21
Johnson, B.M.22
Knipe, J.O.23
Parker, D.D.24
Santone, K.S.25
Fridell, R.A.26
Lemm, J.A.27
Oboyle, D.R.I.I.28
Colonno, R.J.29
Gao, M.30
Meanwell, N.A.31
Hamann, L.G.32
more..
-
45
-
-
52249108100
-
-
3rd ed. Masters, J. R. W. Oxford University Press: Oxford, UK - 219
-
Wilson, A. P. Cytotoxicity and Viability Assays in Animal Cell Culture: A Practical Approach, 3rd ed.; Masters, J. R. W., Eds.; Oxford University Press: Oxford, UK, 2000; pp 175-219.
-
(2000)
Cytotoxicity and Viability Assays in Animal Cell Culture: A Practical Approach
, pp. 175
-
-
Wilson, A.P.1
-
46
-
-
84971222411
-
-
Patent application WO-2010/099527
-
Qiu, Y.-l.; Wang, C.; Peng, X.; Ying, L.; Or, Y. S. Hepatitis C virus inhibitors. Patent application WO-2010/099527, 2010.
-
(2010)
Hepatitis C Virus Inhibitors
-
-
Qiu, Y.-L.1
Wang, C.2
Peng, X.3
Ying, L.4
Or, Y.S.5
-
47
-
-
84907532210
-
-
Patent application US-2010/0316607
-
Or, Y. S.; Peng, X.; Ying, L.; Wang, C.; Qiu, Y.-l. Hepatitis C virus inhibitors. Patent application US-2010/0316607, 2010.
-
(2010)
Hepatitis C Virus Inhibitors
-
-
Or, Y.S.1
Peng, X.2
Ying, L.3
Wang, C.4
-
48
-
-
84907560390
-
-
Patent application US 2012/230951
-
Alam, M.; Berthel, S. J.; Brinkman, J. A.; Hawley, R. C.; Li, H.; Palmer, W. S.; Pietranico-Cole, S.; Sarabu, R.; Smith, M.; So, S.-S.; Yi, L.; Zhai, Y.; Zhang, Q.; Zhao, S.-H. Antiviral compounds. Patent application US 2012/230951, 2012.
-
(2012)
Antiviral Compounds
-
-
Alam, M.1
Berthel, S.J.2
Brinkman, J.A.3
Hawley, R.C.4
Li, H.5
Palmer, W.S.6
Pietranico-Cole, S.7
Sarabu, R.8
Smith, M.9
So, S.-S.10
Yi, L.11
Zhai, Y.12
Zhang, Q.13
Zhao, S.-H.14
-
49
-
-
77957719307
-
Ligand-Accelerated C-H Activation Reactions: Evidence for a Switch of Mechanism
-
Engle, K. M.; Wang, D.-H.; Yu, J.-Q. Ligand-Accelerated C-H Activation Reactions: Evidence for a Switch of Mechanism J. Am. Chem. Soc. 2010, 132, 14137-14151
-
(2010)
J. Am. Chem. Soc.
, vol.132
, pp. 14137-14151
-
-
Engle, K.M.1
Wang, D.-H.2
Yu, J.-Q.3
-
50
-
-
0032493484
-
Bioorg. A new series of cyclic amino acids as inhibitors of S -adenosyl l -methionine synthetase
-
Lavrador, K.; Guillerm, D.; Guillerm, G. Bioorg. A new series of cyclic amino acids as inhibitors of S -adenosyl l -methionine synthetase Med. Chem. Lett. 1998, 8, 1629-1634
-
(1998)
Med. Chem. Lett.
, vol.8
, pp. 1629-1634
-
-
Lavrador, K.1
Guillerm, D.2
Guillerm, G.3
-
51
-
-
84907560389
-
-
Patent application WO-2008/080891
-
Han, Z.; Gerlach, K.; Krishnamurthy, D.; Matthes, B.; Nar, H.; Pfau, R.; Priepke, H.; Schuler-Metz, A.; Senanayake, C. H.; Sieger, P.; Tang, W.; Wienen, W.; Xu, Y.; Yee, N. K. Process for the synthesis of derivatives of 3-amino-tetrahydrofuran-3-carboxylic acid and use thereof as medicaments. Patent application WO-2008/080891, 2008.
-
(2008)
Process for the Synthesis of Derivatives of 3-amino-tetrahydrofuran-3-carboxylic Acid and Use Thereof As Medicaments
-
-
Han, Z.1
Gerlach, K.2
Krishnamurthy, D.3
Matthes, B.4
Nar, H.5
Pfau, R.6
Priepke, H.7
Schuler-Metz, A.8
Senanayake, C.H.9
Sieger, P.10
Tang, W.11
Wienen, W.12
Xu, Y.13
Yee, N.K.14
-
52
-
-
84907560388
-
-
Laboratory of Bioinformatics and Medicinal Chemistry, MIPT(SU); (accessed June 11, 2014)
-
SmartMining; Laboratory of Bioinformatics and Medicinal Chemistry, MIPT(SU); http://phystech.edu (accessed June 11, 2014).
-
SmartMining
-
-
-
53
-
-
84907499283
-
-
ChemDiv, Inc. (accessed June 11, 2014)
-
ChemoSoft; ChemDiv, Inc.; https://www.chemdiv.com (accessed June 11, 2014).
-
ChemoSoft
-
-
-
54
-
-
84959340150
-
-
ChemAxon; (accessed June 11, 2014)
-
Marvin Suite; ChemAxon; https://www.chemaxon.com (accessed June 11, 2014).
-
Marvin Suite
-
-
-
55
-
-
65249098311
-
Comparison of nephelometric, UV-spectroscopic, and HPLC methods for high-throughput determination of aqueous drug solubility in microtiter plates
-
Hoelke, B.; Gieringer, S.; Arlt, M.; Saal, C. Comparison of nephelometric, UV-spectroscopic, and HPLC methods for high-throughput determination of aqueous drug solubility in microtiter plates Anal. Chem. 2009, 81, 3165-3172
-
(2009)
Anal. Chem.
, vol.81
, pp. 3165-3172
-
-
Hoelke, B.1
Gieringer, S.2
Arlt, M.3
Saal, C.4
-
56
-
-
84907560386
-
Application note AN1730EN00, AN1731EN00, protocol note PC2445EN00
-
Application note AN1730EN00, AN1731EN00, protocol note PC2445EN00; Millipore Corp., 2003.
-
(2003)
Millipore Corp.
-
-
-
57
-
-
0032566902
-
Human serum attenuates the activity of protease inhibitors towards wild-type and mutant human immunodeficiency virus
-
Molla, A.; Vasavanonda, S.; Kumar, G.; Sham, H. L.; Johnson, M.; Grabowski, B.; Denissen, J. F.; Kohlbrenner, W.; Plattner, J. J.; Leonard, J. M.; Norbeck, D. W.; Kempf, D. J. Human serum attenuates the activity of protease inhibitors towards wild-type and mutant human immunodeficiency virus Virology 1998, 250, 255-262
-
(1998)
Virology
, vol.250
, pp. 255-262
-
-
Molla, A.1
Vasavanonda, S.2
Kumar, G.3
Sham, H.L.4
Johnson, M.5
Grabowski, B.6
Denissen, J.F.7
Kohlbrenner, W.8
Plattner, J.J.9
Leonard, J.M.10
Norbeck, D.W.11
Kempf, D.J.12
-
58
-
-
0029820967
-
Relevance of plasma protein binding to antiviral activity and clinical efficacy of inhibitors of human immunodeficiency virus protease
-
Bilello, J. A.; Drusano, G. L. Relevance of plasma protein binding to antiviral activity and clinical efficacy of inhibitors of human immunodeficiency virus protease J. Infect. Dis. 1996, 173, 1524-1525
-
(1996)
J. Infect. Dis.
, vol.173
, pp. 1524-1525
-
-
Bilello, J.A.1
Drusano, G.L.2
-
60
-
-
53649084633
-
High-Throughput Microsomal Stability Assay for Screening New Chemical Entities in Drug Discovery
-
Fonsi, M.; Orsale, M.; Monteagudo, E. High-Throughput Microsomal Stability Assay for Screening New Chemical Entities in Drug Discovery J. Biomol. Screening 2008, 13, 862-869
-
(2008)
J. Biomol. Screening
, vol.13
, pp. 862-869
-
-
Fonsi, M.1
Orsale, M.2
Monteagudo, E.3
-
61
-
-
84907560385
-
-
Life Technologies; (accessed June 11, 2014)
-
Predictor hERG Fluorescence Polarization Assay Kit; Life Technologies; http://www.lifetechnologies.com/order/catalog/product/PV5365 (accessed June 11, 2014).
-
Predictor HERG Fluorescence Polarization Assay Kit
-
-
-
62
-
-
0037194634
-
Toward a pharmacophore for drugs inducing the long QT syndrome: Insights from a CoMFA study of HERG K(+) channel blockers
-
Cavalli, A.; Poluzzi, E.; De Ponti, F.; Recanatini, M. Toward a pharmacophore for drugs inducing the long QT syndrome: Insights from a CoMFA study of HERG K(+) channel blockers J. Med. Chem. 2002, 45 (18) 3844-3853
-
(2002)
J. Med. Chem.
, vol.45
, Issue.18
, pp. 3844-3853
-
-
Cavalli, A.1
Poluzzi, E.2
De Ponti, F.3
Recanatini, M.4
-
63
-
-
35548962252
-
Acute toxicity studies and determination of median lethal dose
-
Akhila, J. S.; Deepa, S.; Alwar, M. C. Acute toxicity studies and determination of median lethal dose Curr. Sci. 2007, 93, 917-920
-
(2007)
Curr. Sci.
, vol.93
, pp. 917-920
-
-
Akhila, J.S.1
Deepa, S.2
Alwar, M.C.3
-
64
-
-
0004116672
-
-
Cambridge University Press: Cambridge, UK
-
Finney, D. J. Probit Analysis; Cambridge University Press: Cambridge, UK, 1978.
-
(1978)
Probit Analysis
-
-
Finney, D.J.1
-
65
-
-
0023281076
-
Mammalian in vivo cytogenetic assays. Analysis of chromosome aberrations in bone marrow cells
-
Preston, R. J.; Dean, B. J.; Galloway, S.; Holden, H.; McFee, A. F.; Shelby, M. Mammalian in vivo cytogenetic assays. Analysis of chromosome aberrations in bone marrow cells Mutat. Res. 1987, 189, 157-165
-
(1987)
Mutat. Res.
, vol.189
, pp. 157-165
-
-
Preston, R.J.1
Dean, B.J.2
Galloway, S.3
Holden, H.4
McFee, A.F.5
Shelby, M.6
|